← Open Payments lookup

TODD BATES: Open Payments

NPI 1063008829 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$850 in 18 payments from 10 companies in 2025. Trend: 2023 $1,000 · 2024 $697 · 2025 $850

Food & beverage: $850
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$278
Edwards Lifesciences Corporation2$126
E.R. Squibb & Sons, L.L.C.1$125
Vanda Pharmaceuticals Inc.5$110
Alkermes, Inc.1$95
Janssen Pharmaceuticals, Inc2$36
Boehringer Ingelheim Pharmaceuticals, Inc.1$24
Neurocrine BioSciences, Inc.1$23
Janssen Biotech, Inc.1$17
Otsuka America Pharmaceutical, Inc.1$15

Products named: CAPLYTA, COBENFY, FANAPT, LYBALVI, SAPIEN 3 Ultra RESILIA, INGREZZA, INVEGA SUSTENNA, RYBREVANT.

Industry payments across ID — which companies pay providers there.